736 related articles for article (PubMed ID: 19394376)
1. Targeting cancer by transcriptional control in cancer gene therapy and viral oncolysis.
Dorer DE; Nettelbeck DM
Adv Drug Deliv Rev; 2009 Jul; 61(7-8):554-71. PubMed ID: 19394376
[TBL] [Abstract][Full Text] [Related]
2. Adenovirus-mediated cancer gene therapy and virotherapy (Review).
Fukazawa T; Matsuoka J; Yamatsuji T; Maeda Y; Durbin ML; Naomoto Y
Int J Mol Med; 2010 Jan; 25(1):3-10. PubMed ID: 19956895
[TBL] [Abstract][Full Text] [Related]
3. Oncolytic virotherapy: approaches to tumor targeting and enhancing antitumor effects.
Thorne SH; Hermiston T; Kirn D
Semin Oncol; 2005 Dec; 32(6):537-48. PubMed ID: 16338419
[TBL] [Abstract][Full Text] [Related]
4. Targeting gene-virotherapy of cancer.
Liu XY; Gu JF
Cell Res; 2006 Jan; 16(1):25-30. PubMed ID: 16467873
[TBL] [Abstract][Full Text] [Related]
5. Transcriptionally regulated, prostate-targeted gene therapy for prostate cancer.
Lu Y
Adv Drug Deliv Rev; 2009 Jul; 61(7-8):572-88. PubMed ID: 19393705
[TBL] [Abstract][Full Text] [Related]
6. Viral gene therapy strategies: from basic science to clinical application.
Young LS; Searle PF; Onion D; Mautner V
J Pathol; 2006 Jan; 208(2):299-318. PubMed ID: 16362990
[TBL] [Abstract][Full Text] [Related]
7. A new recombinant vaccinia with targeted deletion of three viral genes: its safety and efficacy as an oncolytic virus.
Yang S; Guo ZS; O'Malley ME; Yin X; Zeh HJ; Bartlett DL
Gene Ther; 2007 Apr; 14(8):638-47. PubMed ID: 17268533
[TBL] [Abstract][Full Text] [Related]
8. [A mini-review of targeting gene-virotherapy of cancer].
Liu XY; Gu JF
Ai Zheng; 2006 Oct; 25(10):1320-2. PubMed ID: 17059786
[TBL] [Abstract][Full Text] [Related]
9. Integrating the biological characteristics of oncolytic viruses and immune cells can optimize therapeutic benefits of cell-based delivery.
Thorne SH; Contag CH
Gene Ther; 2008 May; 15(10):753-8. PubMed ID: 18356814
[TBL] [Abstract][Full Text] [Related]
10. Natural and genetically engineered viral agents for oncolysis and gene therapy of human cancers.
Sinkovics JG; Horvath JC
Arch Immunol Ther Exp (Warsz); 2008 Dec; 56 Suppl 1():3s-59s. PubMed ID: 19104757
[TBL] [Abstract][Full Text] [Related]
11. Reconstituting retroviral (ReCon) vectors facilitating delivery of cytotoxic genes in cancer gene therapy approaches.
Brandtner EM; Kodajova P; Hlavaty J; Jandl G; Tabotta W; Salmons B; Günzburg WH; Hohenadl C
J Gene Med; 2008 Feb; 10(2):113-22. PubMed ID: 18076132
[TBL] [Abstract][Full Text] [Related]
12. A strict-late viral promoter is a strong tumor-specific promoter in the context of an oncolytic herpes simplex virus.
Fu X; Meng F; Tao L; Jin A; Zhang X
Gene Ther; 2003 Aug; 10(17):1458-64. PubMed ID: 12900760
[TBL] [Abstract][Full Text] [Related]
13. Oncolytic adenoviruses for cancer gene therapy.
Liu TC; Thorne SH; Kirn DH
Methods Mol Biol; 2008; 433():243-58. PubMed ID: 18679628
[TBL] [Abstract][Full Text] [Related]
14. Targeting gene-virotherapy of cancer and its prosperity.
Liu XY
Cell Res; 2006 Nov; 16(11):879-86. PubMed ID: 17102812
[TBL] [Abstract][Full Text] [Related]
15. Oncolytic adenoviruses as antiglioma agents.
Jiang H; McCormick F; Lang FF; Gomez-Manzano C; Fueyo J
Expert Rev Anticancer Ther; 2006 May; 6(5):697-708. PubMed ID: 16759161
[TBL] [Abstract][Full Text] [Related]
16. From gene therapy to virotherapy for ovarian cancer.
Stoff-Khalili MA; Dall P; Curiel DT
Minerva Ginecol; 2004 Dec; 56(6):503-14. PubMed ID: 15729203
[TBL] [Abstract][Full Text] [Related]
17. Targeting strategies in cancer gene therapy.
Wang JH; Liu XY
Sheng Wu Hua Xue Yu Sheng Wu Wu Li Xue Bao (Shanghai); 2003 Apr; 35(4):311-6. PubMed ID: 12673383
[TBL] [Abstract][Full Text] [Related]
18. Targeted genetic and viral therapy for advanced head and neck cancers.
Huang PI; Chang JF; Kirn DH; Liu TC
Drug Discov Today; 2009 Jun; 14(11-12):570-8. PubMed ID: 19508919
[TBL] [Abstract][Full Text] [Related]
19. Transcriptional targeting for cancer gene therapy.
Clary BM; Lyerly HK
Surg Oncol Clin N Am; 1998 Jul; 7(3):565-74. PubMed ID: 9624217
[TBL] [Abstract][Full Text] [Related]
20. Generation of a recombinant oncolytic Newcastle disease virus and expression of a full IgG antibody from two transgenes.
Pühler F; Willuda J; Puhlmann J; Mumberg D; Römer-Oberdörfer A; Beier R
Gene Ther; 2008 Mar; 15(5):371-83. PubMed ID: 18200068
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]